Profile cover photo
Profile photo
BioPortfolio
215 followers -
The life science and healthcare portal
The life science and healthcare portal

215 followers
About
Posts

Post has attachment
ICYMI: #biotechnology #biotechnology Huami Corporation Enters Partnership with PAI Health to Offer Health Risk Services to the Insurance Industry: BEIJING July 19 2018 PRNewswire Huami Corporation "Huami" or the "Company" NYSE HMI a biometric and activity datadriven company with significant expertise in smart wearable technology today announced that it has signed ...
Add a comment...

Post has attachment
FYI: #biotechnology #biotechnology Update on Progress of Broad Spectrum Antibiotic RECCEÂ327 Towards Clinical Trials: SYDNEY Australia 17 July 2018 Recce Pharmaceuticals Ltd ASXRCE Company the Company developing a new class of synthetic broad spectrum antibiotics today provided an update on its progress towards the start of human trials of its lead compound RECCE&...
Add a comment...

Post has attachment
ICYMI: #biotechnology #biotechnology Allergan and Molecular Partners Announce Two Positive Phase 3 Clinical Trials for Abicipar pegol ...: Allergan plc a leading global pharmaceutical company and Molecular Partners a clinicalstage biopharmaceutical company developing a new class of drugs known as DARPin therapies today announced the release of two positive clinical trials.
Add a comment...

Post has attachment
ICYMI: #biotechnology #biotechnology Gottlieb Slams Pharma Launches Biosimilars Pathway: In a speech given at the Brookings Institution preceding the release of the U.S. Food and Drug Administration FDAs Biosimilars Action Plan FDA Commissioner Scott Gottlieb unloaded on big pharma.
Add a comment...

Post has attachment
ICYMI: #biotechnology #biotechnology Cannabisstocks MPX CSEMPX OTCMPXEF Enters Into Extraction Agreement With Southern California's Largest Cannabis Processing Facility Case Farms Collective: TORONTO July 19 2018 Investorideas.com Newswire MPX Bioceutical Corporation "MPX" or the "Company" CSEMPX OTCMPXEF today announced an agreement with Case Farms Collective "Case Farms" the largest cannabis processing facility ...
Add a comment...

Post has attachment
ICYMI: #biotechnology #biotechnology Vertical Companies and Galenas Form Strategic Partnership for the Ohio Legal Medical Cannabis Market: Vertical www.vertcos.com and Galenas are pleased to announce a strategic partnership between the two businesses. Vertical is among the first and largest vertically integrated companies in the legal cannabis industry. Galenas is a ...
Add a comment...

Post has attachment
#biotechnology Ziegler Hires Corporate Finance Healthcare Banker Christopher Utz: Ziegler a national specialty investment bank announced today the addition of Christopher Utz as a director to its corporate finance team specializing in proprietary senior living.CHICAGO PRWEB July 20 2018 Ziegler a national specialty investment bank anno...
Add a comment...

Post has attachment
#biotechnology ReNeuron Group RENE Exosomes rise further: Edison Investment Research Pharmaceutical & healthcare ReNeuron Group ReNeuron’s capital markets day highlighted the potential for the company’s exosome nanomedicine platform to be a source of both product and licensing revenues. ...
Add a comment...

Post has attachment
#biotechnology #biotechnology Global Aptamers Market Segmented by Type of Products and Applications Growth Trends and Forecasts 2018 2023 Report Updated 08022018 Prices from USD $4250: The global Aptamers market has been estimated to reach USD 401.30 billion in 2023. The market is expected to register a CAGR of 17.89 during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological advancemen...
Add a comment...

Post has attachment
ICYMI: #biotechnology #biotechnology FDA Releases Biosimilars Action Plan Along With Some Harsh Words For Drug Manufacturers: The FDA released theÂBiosimilars Action Plan BAP on Wednesday which details the key actions the agency is taking to encourage innovation and competition among biologics and the development of biosimilars.Â
Add a comment...
Wait while more posts are being loaded